The UAMS College of Pharmacy offers a wide range of student pharmacist research opportunities in the areas of pharmaceutical, biomedical, social, behavioral, administrative and clinical pharmacy. As research is a cornerstone to the future of the pharmacy profession, our faculty have made a commitment that research be an integral component of the students’ education.
All applications are due to the UAMS College of Pharmacy Research Committee at BSTeeter@uams.edu by close of business on March 8, 2024.
2024 Summer Research Opportunities
- Dr. Ashim Bagchi, PhD
Understanding the Pathophysiology of Doxorubicin-induced Cardio-lymphotoxicity - Dr. Brett Bailey, PharmD, Dr. Laken Jones, PharmD & Dr. Lara Rains, PharmD
A Retrospective Review of Outpatient Pharmacy Adherence Rates and Quality Measures since Implementation of a Medication Therapy Management (MTM) Program in 2020 - Dr. Meghan Breckling, PharmD
Arkansas Naloxone Education Training (ANET) Program - Dr. Lindsey Dayer, PharmD & Dr. Jacob Painter, PharmD, PhD
The Effect of Concurrent Use of Opioids and Skeletal Muscle Relaxants on Fall Risk in Older Adults - Dr. Amanda Elchynski, PharmD & Dr. Holly Maples, PharmD
Advancing Pharmacogenomics in a Children’s Hospital - Dr. Brendan Frett, PhD
Discovery of Precision Medicine for Human Disease - Dr. John Imig, PhD
Development of Novel Therapeutics for Cardiovascular and Kidney Diseases - Dr. Holly Maples, PharmD
Implementing and Assessing Strategies to Improve Antibiotic Usage, Diagnostic Testing, and Narrowing the Gap in Health Disparities in Pediatric Infections - Dr. Bahaa Mustafa, PhD
Discovery of Short Peptide Targeting “Do Not Eat Me” Signal CD47 For Cancer Immunotherapy - Dr. Marty Perry, PhD
Authoring POGIL Activities and Other Active Learning Materials for P1/P2 Courses - Dr. Megan Smith, PharmD
Reaching Every Arkansan by Connecting Health (REACH) Resources to Reduce Diabetes Disparities - Dr. Amanda Stolarz, PharmD, PhD
Developing Treatment Strategies to Prevent Cancer-Related Lymphedema - Dr. Maya Wai, PharmD
Tocilizumab Use in Severe Hospitalized COVID-19 Infection